NEUROCRINE BIOSCIENCES INC
NEUROCRINE BIOSCIENCES INC
Action · US64125C1099 · NBIX · 900964 (XNAS)
Aperçu Indicateurs financiers
125,39 USD
0,63 % 0,78 USD
NASDAQ (XNAS) · Cours et graphiques actuels sur MoneyPeak
06.06.2025 20:00

Cours actuels de NEUROCRINE BIOSCIENCES INC

BourseTickerDeviseDernier échangeCoursVariation journalière
XNAS: NASDAQ
NASDAQ
NBIX
USD
06.06.2025 20:00
125,39 USD
124,61 USD
+0,63 %
XLON: London
London
0K6R.L
USD
06.06.2025 15:14
125,49 USD
124,61 USD
+0,71 %

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
0,00 % 1,93 % 5,44 % 11,30 % -2,26 % -7,37 % 8,23 %

Profil de l'entreprise pour NEUROCRINE BIOSCIENCES INC Action

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, a VMAT2 inhibitor for the treatment of tardive dyskinesia. The company's commercial products include ONGENTYS, a catechol-O-methyltransferase inhibitor used as an adjunct therapy to levodopa/DOPA decarboxylase inhibitors for patients with Parkinson's disease; ORILISSA for the management of moderate to severe endometriosis pain in women; and ORIAHNN, a non-surgical oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. Its product candidates in clinical development include NBI-921352 for treating pediatric patients, as well as adult focal epilepsy indications; and NBI-827104 to treat rare pediatric epilepsy and essential tremor. The company's products in clinical development also comprise NBI-1065845 for the treatment of major depressive disorder; NBI-1065846 for treating anhedonia in major depressive disorder; and NBI-118568 for the treatment of schizophrenia. It has license and collaboration agreements with Heptares Therapeutics Limited; Takeda Pharmaceutical Company Limited; Idorsia Pharmaceuticals Ltd; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; BIAL – Portela & Ca, S.A.; Mitsubishi Tanabe Pharma Corporation; and AbbVie Inc. Neurocrine Biosciences, Inc. was incorporated in 1992 and is headquartered in San Diego, California.

Fonds investis

Les fonds suivants ont investi dans : NEUROCRINE BIOSCIENCES INC investi :

Fonds
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. en millions
301,42
Part (%)
0,71 %
Fonds
iShares MSCI World Health Care Sector UCITS ETF USD (Dist)
Vol. en millions
394,22
Part (%)
0,11 %
Fonds
iShares MSCI USA ESG Screened UCITS ETF USD (Acc)
Vol. en millions
873,57
Part (%)
0,02 %
Fonds
iShares MSCI USA ESG Screened UCITS ETF USD (Dist)
Vol. en millions
84,66
Part (%)
0,02 %
Fonds
iShares Core MSCI World UCITS ETF EUR Hedged (Dist)
Vol. en millions
112,22
Part (%)
0,01 %

Données de l'entreprise

Nom NEUROCRINE BIOSCIENCES INC
Société Neurocrine Biosciences, Inc.
Symbole NBIX
Site web https://www.neurocrine.com
Marché d'origine XNAS NASDAQ
WKN 900964
ISIN US64125C1099
Type de titre Action
Secteur Healthcare
Industrie Medical - Pharmaceuticals
PDG Mr. Kyle W. Gano Ph.D.
Capitalisation boursière 10 Mrd.
Pays États-Unis d'Amérique
Devise USD
Employés 1,8 T
Adresse 12780 El Camino Real, 92130 San Diego
Date d'introduction en bourse 2018-01-29

Symboles boursiers

Nom Symbole
Frankfurt NB3.F
London 0K6R.L
NASDAQ NBIX

Autres actions

Les investisseurs qui détiennent NEUROCRINE BIOSCIENCES INC ont également les actions suivantes dans leur portefeuille :
ADVANCED MICRO DEVICES INC
ADVANCED MICRO DEVICES INC Action
AMAZON.CO INC
AMAZON.CO INC Action
APPLE INC
APPLE INC Action
AUTODESK INC
AUTODESK INC Action
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Action
FST SENT-SI IND.SC S.AEOA
FST SENT-SI IND.SC S.AEOA Fonds
LEGACY HOUSING CORP
LEGACY HOUSING CORP Action
MICRON TECHNOLOGIESLOGY INC
MICRON TECHNOLOGIESLOGY INC Action
NETFLIX INC
NETFLIX INC Action
PAYPAL INC
PAYPAL INC Action
QUALCOMM INC
QUALCOMM INC Action
TAITRON COMPONENTS INC - CLASS A
TAITRON COMPONENTS INC - CLASS A Action
VERTEX PHARMACEUTICALS INC
VERTEX PHARMACEUTICALS INC Action
YOURGENE HEALTH  LS 0,001
YOURGENE HEALTH LS 0,001 Action
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025